drugset / Trial / NCT04024527

High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

NCT04024527

Phase 4 Completed 306 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupSingle-blindTreatment

Summary

Dual therapy containing high dose of proton pump inhibitor (PPI) and amoxicillin had showed excellent eradication results with Helicobacter pylori first-line treatment. However, no study has examined the the efficacy of high dose of dual therapy or dual therapy plus metronidazole for H. pylori rescue treatment.This study is designed to evaluate the efficacy and safety of the addition of metronidazole to high dose of dual therapy for H. pylori rescue treatment.

Timeline

Start
2019-07-25
Primary completion
2021-04-12
Completion
2021-05-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 0.4 g
Background Amoxicillin Other / unclassified 1 g
Background Esomeprazole Small molecule 40 mg